Q-omics provides the consensus-scored DNAAF4-CCPG1 profile across patient tissues and cancer cell-line models. DNAAF4-CCPG1 expression is associated with patient survival in 18 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, DNAAF4-CCPG1 is differentially expressed in 4, with the highest sampling consensus in THCA. Additionally, DNAAF4-CCPG1 RNA expression shows 11,668 significant gene co-expression associations, with the highest sampling consensus in THYM. Together, these results highlight READ, THCA, and THYM as cancer lineages where DNAAF4-CCPG1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for DNAAF4-CCPG1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes DNAAF4-CCPG1 survival associations across molecular data types. DNAAF4-CCPG1 RNA expression shows survival associations in the most cancer types (18). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible DNAAF4-CCPG1 RNA expression–survival associations across cancer types. High DNAAF4-CCPG1 expression shows unfavorable associations in READ, MESO, CHOL, COAD and UCEC, but favorable associations in ACC. The READ Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for DNAAF4-CCPG1 RNA expression.
This table summarizes DNAAF4-CCPG1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for DNAAF4-CCPG1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. DNAAF4-CCPG1 shows lower tumor expression in THCA, KICH, LUAD and LUSC. The THCA box plot shows higher DNAAF4-CCPG1 RNA expression in normal versus tumor tissue (log2 FC = −0.102, t-test p < 0.001).
This table shows molecular features associated with DNAAF4-CCPG1 in patient tissues and cancer cell lines. In patient samples, DNAAF4-CCPG1 shows the broadest associations at the RNA and protein expression levels, with THYM recurring as the lineage with the largest associated feature set. In cancer cell lines, DNAAF4-CCPG1 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BREAST, while CRISPR and shRNA rows add functional-dependency signals in LUNG_SCLC.
